Periodic Report
CJ Bioscience sold KRW 0.9 billion in Q3 and lost KRW 4.9 billion from its main business, a smaller loss than KRW 6.1 billion a year earlier.
311690 · KOSDAQ · Based on DART filings
2 total · 20 per page
CJ Bioscience sold KRW 0.9 billion in Q3 and lost KRW 4.9 billion from its main business, a smaller loss than KRW 6.1 billion a year earlier.
Subsidiary EzBiome will issue 185,667 new shares at KRW 40,671 each to raise KRW 7.3 billion for debt repayment and KRW 0.3 billion for operations.
Get app alerts for new disclosures from CJ Bioscience.